Article
Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5.
Circulation research - 25 Nov 2005
Fujiu Katsuhito, Manabe Ichiro, Ishihara Atsushi, Oishi Yumiko, Iwata Hiroshi, Nishimura Go, Shindo Takayuki, Maemura Koji, Kagechika Hiroyuki, Shudo Koichi, Nagai Ryozo
Abstract excerpt
Modulation of smooth muscle cell (SMC) phenotype plays a central role in neointima formation. We recently demonstrated that Am80, a synthetic retinoic acid receptor alpha-specific agonist, inhibits the activity of the transcription factor KLF5, which is essential for neointima formation after vascular injury. In the present study, we aimed to further analyze the mechanism by which Am80 inhibits KLF5 and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
